Cargando…

Efficacy of TTFields in high-grade gliomas: a protocol for systematic review and meta-analysis

INTRODUCTION: Despite their recent FDA(Food and Drug Administration) approval, tumour treatment fields (TTFields) have not seen acceptance as part of standard of care (SOC) for the treatment of high-grade gliomas (HGGs). Few studies have reported the clinical effect of simultaneous or sequential use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinlong, Wang, Juncheng, Yuan, Guoqiang, Pan, Yawen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514625/ https://www.ncbi.nlm.nih.gov/pubmed/37730390 http://dx.doi.org/10.1136/bmjopen-2023-073753

Ejemplares similares

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
por: Li, Shupeng, et al.
Publicado: (2022)

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020)

Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review
por: Solomou, Georgios, et al.
Publicado: (2022)

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2021)

Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study
por: Onken, Julia, et al.
Publicado: (2019)

Gross Total vs. Subtotal Resection on Survival Outcomes in Elderly Patients With High-Grade Glioma: A Systematic Review and Meta-Analysis
por: Han, Qian, et al.
Publicado: (2020)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
por: Warren, Kwanza T., et al.
Publicado: (2019)

The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis
por: Shen, Fangcheng, et al.
Publicado: (2023)

Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid–Guided Surgery: A Systematic Review and Meta-Analysis
por: Gandhi, Sirin, et al.
Publicado: (2019)

Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis
por: Wang, Huan, et al.
Publicado: (2021)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Chromatin mutations in pediatric high grade gliomas
por: Voon, Hsiao P. J., et al.
Publicado: (2023)

Ozone therapy for high-grade glioma: an overview
por: Yanchu, Li, et al.
Publicado: (2023)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

Machine Learning Models for Classifying High- and Low-Grade Gliomas: A Systematic Review and Quality of Reporting Analysis
por: Bahar, Ryan C., et al.
Publicado: (2022)

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region
por: Anadkat, Milan J., et al.
Publicado: (2023)

CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
por: Tian, Guopeng, et al.
Publicado: (2023)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data
por: Goldman, Stewart, et al.
Publicado: (2022)

Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Publicado: (2022)

Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and Biology
por: Fangusaro, Jason
Publicado: (2012)

A Multi-Institutional Experience in Pediatric High-Grade Glioma
por: Walston, Steve, et al.
Publicado: (2015)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
por: Metselaar, Dennis S., et al.
Publicado: (2021)

ErbB4 in the brain: Focus on high grade glioma
por: Pitcher, Jamie-Lee, et al.
Publicado: (2022)

OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/β-Catenin Signaling
por: Ma, Shize, et al.
Publicado: (2021)

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma
por: Ricker, Cora A., et al.
Publicado: (2016)

Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays
por: Li, Xing, et al.
Publicado: (2022)

Accuracy of CT texture analysis for differentiating low-grade and high-grade renal cell carcinoma: systematic review and meta-analysis
por: Yu, Wei, et al.
Publicado: (2021)

Safety, efficacy and immunogenicity of therapeutic vaccines in the treatment of patients with high-grade cervical intraepithelial neoplasia associated with human papillomavirus: a systematic review protocol
por: Gonçalves, Caroline Amélia, et al.
Publicado: (2019)

Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas
por: Yuan, Taoyang, et al.
Publicado: (2020)

Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis
por: Sun, Wanyi, et al.
Publicado: (2023)

Commentary on: “A Multi-Institutional Experience in Pediatric High Grade Glioma”
por: Caffo, Maria
Publicado: (2015)

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017)

Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients
por: Dutoit, Valérie, et al.
Publicado: (2020)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvlvjmn5r8ei0h1udkbp14dhin